Literature DB >> 10591414

Amyloid beta peptide membrane perturbation is the basis for its biological effects.

J N Kanfer1, G Sorrentino, D S Sitar.   

Abstract

Experimental studies have indicated that the mechanisms offered for explaining the neurotoxicity of amyloid beta peptide (AbetaP) are diverse, and include altered enzyme activities, disrupted calcium homeostasis, and increased free radical formation. AbetaP appears to interact at the cell membrane with a multitude of receptor sites and also inserts physically into the membrane matrix. This membrane insertion affects the membrane fluidity and potentially influences the function of resident membrane proteins. We propose a unifying hypothesis to explain the experimental observations of the diverse cellular responses to AbetaP. The indiscriminate physical insertion of AbetaP into the cell membrane unspecifically activates a host of membrane processes by perturbation of the membrane proteins. This recurrent activation of membrane processes eventually culminates in neuronal cell death. We recommend that successful therapeutic interventions should be directed at reducing or preventing the interaction of AbetaP with neuronal cell membranes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591414     DOI: 10.1023/a:1021172620295

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  110 in total

1.  Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells.

Authors:  I N Singh; G Sorrentino; J N Kanfer
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

2.  The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets.

Authors:  P S Tappia; S Ladha; D C Clark; R F Grimble
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus.

Authors:  J Wu; R Anwyl; M J Rowan
Journal:  Neuroreport       Date:  1995-11-27       Impact factor: 1.837

4.  Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.

Authors:  T Pillot; M Goethals; B Vanloo; C Talussot; R Brasseur; J Vandekerckhove; M Rosseneu; L Lins
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

5.  Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.

Authors:  G S Zubenko; I Teply; E Winwood; F J Huff; J Moossy; T Sunderland; A J Martinez
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

6.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

7.  Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture.

Authors:  H W de Jonge; D H Dekkers; E M Bastiaanse; K Bezstarosti; A van der Laarse; J M Lamers
Journal:  J Mol Cell Cardiol       Date:  1996-05       Impact factor: 5.000

8.  Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5.

Authors:  J K Singh; A Dasgupta; T Adayev; S A Shahmehdi; D Hammond; P Banerjee
Journal:  Biochim Biophys Acta       Date:  1996-12-13

9.  Hippocampal membrane alteration in Alzheimer's disease.

Authors:  G S Zubenko
Journal:  Brain Res       Date:  1986-10-15       Impact factor: 3.252

10.  Reduction of adenosine A1-receptors in the perforant pathway terminal zone in Alzheimer hippocampus.

Authors:  D Jaarsma; J B Sebens; J Korf
Journal:  Neurosci Lett       Date:  1991-01-02       Impact factor: 3.046

View more
  4 in total

1.  C-terminal fragments of amyloid-beta peptide cause cholinergic axonal degeneration by a toxic effect rather than by physical injury in the nondemented human brain.

Authors:  Peter Kasa; Henrietta Papp; Janos Zombori; Peter Mayer; Frederic Checler
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.

Authors:  Melinda Erzsébet Tóth; Viktor Szegedi; Edina Varga; Gábor Juhász; János Horváth; Emőke Borbély; Balázs Csibrány; Róbert Alföldi; Nikolett Lénárt; Botond Penke; Miklós Sántha
Journal:  Cell Stress Chaperones       Date:  2013-04-21       Impact factor: 3.667

3.  Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer's Disease.

Authors:  Arianna Polverino; Manuela Grimaldi; Pierpaolo Sorrentino; Francesca Jacini; Anna Maria D'Ursi; Giuseppe Sorrentino
Journal:  Cell Mol Neurobiol       Date:  2017-10-09       Impact factor: 5.046

4.  Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.

Authors:  S Nair; M Traini; I W Dawes; G G Perrone
Journal:  Mol Biol Cell       Date:  2014-05-28       Impact factor: 4.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.